Market News & Trends
CureVac Enters Exclusive Collaborative Research Agreement
CureVac AG recently announced it has entered into a Collaborative Research Agreement with Yale University for discovery research into mRNA-based……
Saama & Comprehend to Form Preeminent Clinical Analytics Platform Company
Saama Technologies, Inc. recently announced it has signed a definitive agreement to acquire Comprehend Systems, Inc. to create an exciting, enhanced suite of………..
Co-Processed Excipient for Direct Compression Designed for Orally Disintegrating Tablets
Developing ODTs is a worldwide trend. In recent years, new excipients and excipient blends have enabled manufacturers to produce ODTs using conventional equipment, ie, blenders and tablet presses. One such product is GRANFILLER-D………
INmune Bio Reports Positive Preliminary Data from INB03 Phase 1 Clinical Trial
INmune Bio, Inc. recently reported positive preliminary data during a presentation at Cambridge Healthtech Institute’s 7th Annual Immuno-Oncology Summit in Boston. INB03 is being developed…
Aquinox Pharmaceuticals & Neoleukin Therapeutics Announce Merger Agreement
Aquinox Pharmaceuticals, Inc. and Neoleukin Therapeutics, Inc. recently announced the two companies entered into a definitive merger agreement under which Aquinox agreed to the acquisition…
Celsion Announces Data Lock for First Interim Analysis in OPTIMA Phase 3 Study
Celsion Corporation recently announces the prescribed number of events has been reached for the first prespecified interim analysis of the OPTIMA Phase 3 Study with…
Eureka Therapeutics Announces Initiation of Phase 1/2 Clinical Trial
Eureka Therapeutics, Inc. recently announced initiation of Phase 1/2 clinical trial of ET140202 ARTEMIS T-cell therapy in liver cancer at City of Hope, a world-renowned…
Cytel Launches East On Demand Bringing Adaptive Clinical Trial Design Capabilities to Wider Biopharma Audience
Cytel Inc. recently announced that it will launch East On Demand at the annual Joint Statistical Meetings (JSM) 2019 (July 27-August 1, Denver, CO). Offered…
Oncternal Therapeutics Announces Opening of Randomized Phase 2 Study
Oncternal Therapeutics, Inc. recently announced it has opened for enrollment its randomized Phase 2 study of cirmtuzumab, a ROR1-targeted monoclonal antibody, combined with ibrutinib in…
Creating Your Secondary Packaging Strategy - Begin With the End in Mind
Whether it is meeting the needs of a rapidly aging market, blocking drug counterfeiters, or differentiating your pharmaceutical product in the market, a secondary packaging program is an important factor in………
MilliporeSigma Acquires BSSN Software to Accelerate Customers’ Digital Transformation in the Lab
MilliporeSigma has acquired BSSN Software, a Darmstadt, Germany-based laboratory informatics company that makes data more readily accessible for ease of integration, collaboration, analysis and…..
Huge Untapped Potential for Rheumatoid Arthritis Treatment by Targeting OX40
A new study led by experts from the University of Tsukuba first published in Annals of the Rheumatic Diseases in July found that OX40-expressing follicular helper T cells contributed to inflammation by regulating……
Spring Bank Announces Collaborative Research Agreement with University of Texas Southwestern Medical School
Spring Bank Pharmaceuticals, Inc. recently announced that it has entered into a research agreement with the University of Texas Southwestern Medical School to evaluate….
Colorcon & TruTag Technologies Enter Development Agreement
Colorcon and TruTag Technologies, Inc. recently announced execution of a development agreement to enable on-dose verification technology for tablets by combining TruTag’s….
Cambrex to be Acquired by the Permira Funds
Cambrex Corporation recently announced it has signed a definitive agreement to be acquired by an affiliate of the Permira funds in a transaction valued at approximately……
Cambrex to Double Size of Edinburgh Solid Form Screening Facility
Cambrex Corporation, the leading small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle, today announced that it is…
Mino-Wrap to be Developed Through an IND Process
Citius Pharmaceuticals, Inc. recently reported the company's decision to develop Mino-Wrap as a drug through the Investigational New Drug (IND) process. The FDA's IND program…
Principia Announces Update to Ongoing Phase 2 Clinical Trial
Principia Biopharma Inc. recently announced updates to its immune thrombocytopenia (ITP) program for PRN1008. The ongoing open-label, dose-finding clinical trial investigating PRN1008 in patients with…
MariMed Signs Multi-State Licensing Agreement
MariMed Inc. recently announced a licensing agreement with Denver-based Binske, which offers an innovative range of diverse cannabis products. Under the terms of the agreements,…
Foamix Announces $64-Million Capital Financing Investment by Perceptive Advisors & OrbiMed
Foamix Pharmaceuticals Ltd. recently announced it has secured up to $64 million in financing from Perceptive Advisors and OrbiMed. The financing consists of term loans…
